BECN1 and urinary bladder cancer: However, some studies have found that Beclin-1 is expressed at low levels in bladder cancer (30), salivary gland adenoid cystic carcinoma (31), and pancreatic ductal adenocarcinoma (32) and that patients with low Beclin-1 expression have shorter survival times.